Back to Search Start Over

Approvals in 2022: overall survival, dose optimization, new approvals and beyond

Authors :
Deepti Telaraja
Nicole Gormley
Richard Pazdur
Source :
Nature Reviews Clinical Oncology. 20:207-208
Publication Year :
2023
Publisher :
Springer Science and Business Media LLC, 2023.

Subjects

Subjects :
Oncology

Details

ISSN :
17594782 and 17594774
Volume :
20
Database :
OpenAIRE
Journal :
Nature Reviews Clinical Oncology
Accession number :
edsair.doi...........bce9b9196ca9f3c93189e35e7e44367a
Full Text :
https://doi.org/10.1038/s41571-023-00741-6